Statin Therapy for Vascular Failure-Reference-Cited by-同舟云学术

Statin Therapy for Vascular Failure

Published:2007-08-08 Issue:4 Volume:21 Page:281-295
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Inoue Teruo,Node Koichi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-007-6038-y.pdf

Reference129 articles.

1. Inoue T, Node K. Vascular failure—a new clinical entity for vascular disease. J Hypertens 2006;24:2121–30.

2. West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipid levels on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998;97:1440–5.

3. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615–22.

4. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9.

5. Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. J Am Coll Cardiol 2001;38:56–63.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atorvastatin Calcium Ameliorates Cognitive Deficits Through the AMPK/Mtor Pathway in Rats with Vascular Dementia;Combinatorial Chemistry & High Throughput Screening;2024-01

2. Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis;European Journal of Hospital Pharmacy;2022-06-21

3. Repeated In-Stent Restenosis Despite Aggressive Lipid Loweringby PCSK-9 Inhibitor Treatment: A Case Report;The Tohoku Journal of Experimental Medicine;2021

4. Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia;Hypertension Research;2019-08-13

5. Do antilipidemic agents reduce blood pressure?;Vascular Failure;2018-03-31